Pfizer requests FDA authorization for Covid-19 booster for kids 5 through 11

Pfizer and BioNTech said Tuesday that they have submitted an application to the US Food and Drug Administration for emergency use authorization of a booster dose of Covid-19 vaccine for children 5 through 11.